No Detail Found!

Spectrum of Acute Leukemias and Aberrant Markers Expression Based on Flowcytometry in a Tertiary Care Centre.

Author(s)
Hamid Nawaz Tipu Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Muhammad Mukarram Bashir Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Chaudhry Altaf Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Muhammad Noman Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Hamid Saeed Malik Armed Forces Institute of Pathology (AFIP), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Abstract
Objective: To determine frequency of different types of leukemias and aberrant CD markers expression on these types. Study Design: Descriptive study. Place and Duration of Study: Department of Immunology, Armed Forces Institute of Pathology, Rawalpindi from Jul 2015 to Dec 2015. Material and Methods: All peripheral blood and bone marrow samples to confirm the suspicion of acute leukemia with flow cytometric immunephenoltyping were included in the study. Cells were stained with lineage specific monoclonal antibodies against cell specific CD markers through lyse wash procedure. Cell acquisition and analysis was done on Cell Quest software in multi parameter flow cytometer. Data was entered in SPSS v 20.0 to determine the frequencies of different types of leukemias and aberrant CD markers expression. Results: Over 6 months, 102 males and 49 females were tested with mean age 26 ± 21 years. Commonest leukemia was AML M2. Among 69 pediatric cases with mean age 7.4 ± 5.8 years, precursor B ALL was commonest. Among 82 adults with mean age 41.5 ± 15.7 years, AML M2 was commonest leukemia. Total 32 cases (18 children and 12 adults) expressed cross lineage aberrant markers, CD13, CD33 and CD7. Conclusion: Aberrant CD markers expression must be kept in mind during lineage assignment of acute leukemias while performing flow cytometric immunophenotyping.
Publication Details
Page(s) 450-454
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 3, Year: 2018

Request the full text from PASTIC

References
VardimanJW,ThieleJ,ArberDA,BrunningRD,BorowitzMJ,PorwitA, 2009.The 2008 Revision of the World Health Organization (WHO) Classification of Myeloid Neoplasms and Acute Leukemias: Rationale and Important changes,Blood 114 937 -51
PatelK,LotodoT,NjugunaF,EmonyiW,MiningS,BuzibaN.,ReferralHospital, 2015.Use of Flow Cytometry Immunophenotyping for Diagnosis of Acute Leukemia at Moi Teaching,Technology and Sciences 13 72 -80
JenningCD, 1997.Foon KA. Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy,Blood 90 2863 -92
PetersJM,Ansari MQ, 2011.Multiparameter flow cytometry in the diagnosis and management of acute leukemia,Arch Pathol Lab Med 135 44 -54
YuanTT,LiuYR,ChangY,HaoL,WangYZ,JiangB, 2011.Characteristics of T-cell Lineage Immunopphenotype in 95 Patients with Acute Lymphoid Leukemia, 19 1134 -40
AlhanC,WestersTM,van der HelmLH,EeltinkC,HulsG,WitteBI,Part B (Clinical Cytometry, 2014.Absence of Aberrant Myeloid Progenitors by Flow Cytometry is Associated with Favorable Response to Azacitidine in Higher Risk Myelodysplastic Syndromes, 207 -15
KhurramMM,JafriSA,MannanA,NadeemA,JamalA, 2010.Frequency of Aberrant Expression of CD Markers in Cases of Acute Leukemia,Med J Islamic World Acad Sci 18 55 -60
2013.Definition of key terms,consolidated ARV -
CraigFE,FoonKA, 2008.Flow cytometric Immunophenotyping for Hematologic Neoplasms,Blood 111 3941 -67
KhurramMM,JafriSA,MannanA,NadeemA,JamalA, 2010.Frequency of aberrant expresson of cd markers in cases of acute leukemia,Med J Islamic world Acad Sci 18 55 -60
KojuS,SachdevaMUS,BoseP,VarmaN., 2015.Spectrum of acute leukemias diagnosed on flow cytometry: analysis from tertiary care centre from north india,ACCLM 1 12 -15
SeegmillerAC,KroftSH,KarandikarJ,MckennaRW, 2009.Characterization of Immunophenotypic Aberrancies in 200 Cases of Acute Lymphoblastic Leukemia,Am J Clin Pathol 132 940 -9
KhawajaMR,AllanaSS,AkbaraliAN,AdilSN,KhurshidM,Pervez S, 2005.,Flow cytometric and Demographic Analysis of T Cell Acute Lymphoblastic Leukemia in Pakistani Population J Ayub Med Coll Abbotabad 17 -
MazherN,MalikN,ImranA,ChughtaiO,ChughtaiAS, 2013.Aberrant Expression of CD Markers in Acute Leukemia,Ann Pak Inst Med Sci 9 99 -102
SarmaA,HazarikaM,DasD,Kumar RaiA,SharmaJD,BhuyanC, 2015.Expression of Aberrant CD Markers in Acute Leukemia: A Study of 100 Cases with Immunophenotyping with Multiparameter Flowcytometry,Cancer Biomarkers 15 501 -5
0

Citations

0

Downloads

90

Views